Charles River Laboratories International Inc (CRL)
239.59
+7.03
(+3.02%)
USD |
NYSE |
Apr 23, 10:06
Charles River Laboratories International Cash from Investing (TTM): -563.16M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -563.16M |
September 30, 2023 | -280.40M |
June 30, 2023 | -293.03M |
March 31, 2023 | -678.54M |
December 31, 2022 | -607.92M |
September 30, 2022 | -643.00M |
June 30, 2022 | -905.86M |
March 31, 2022 | -1.398B |
December 31, 2021 | -1.438B |
September 30, 2021 | -1.536B |
June 30, 2021 | -1.251B |
March 31, 2021 | -325.86M |
December 31, 2020 | -601.54M |
September 30, 2020 | -583.99M |
June 30, 2020 | -574.58M |
March 31, 2020 | -1.074B |
December 31, 2019 | -681.50M |
September 30, 2019 | -681.59M |
June 30, 2019 | -653.20M |
March 31, 2019 | -951.15M |
December 31, 2018 | -955.00M |
September 30, 2018 | -916.87M |
June 30, 2018 | -937.65M |
March 31, 2018 | -150.25M |
December 31, 2017 | -72.59M |
Date | Value |
---|---|
September 30, 2017 | -114.76M |
June 30, 2017 | -73.87M |
March 31, 2017 | -633.23M |
December 31, 2016 | -692.67M |
September 30, 2016 | -696.31M |
June 30, 2016 | -895.90M |
March 31, 2016 | -321.76M |
December 31, 2015 | -327.62M |
September 30, 2015 | -329.78M |
June 30, 2015 | -131.98M |
March 31, 2015 | -303.77M |
December 31, 2014 | -297.99M |
September 30, 2014 | -236.90M |
June 30, 2014 | -236.56M |
March 31, 2014 | -51.78M |
December 31, 2013 | -74.05M |
September 30, 2013 | -74.11M |
June 30, 2013 | -86.40M |
March 31, 2013 | -80.49M |
December 31, 2012 | -54.99M |
September 30, 2012 | -59.81M |
June 30, 2012 | -37.34M |
March 31, 2012 | -27.39M |
December 31, 2011 | -36.64M |
September 30, 2011 | -23.67M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.536B
Minimum
Sep 2021
-280.40M
Maximum
Sep 2023
-777.45M
Average
-653.20M
Median
Jun 2019
Cash from Investing (TTM) Benchmarks
Cardinal Health Inc | -465.00M |
Stryker Corp | -962.00M |
DaVita Inc | -771.80M |
Inotiv Inc | -24.64M |
Medpace Holdings Inc | -34.63M |